跳至主要内容
临床试验/ISRCTN15499304
ISRCTN15499304进行中(未招募)未知

Zurich SARS-CoV-2 Vaccine Cohort (ZVAC): Development of immunity after SARS-CoV-2 vaccination

niversity of Zurich0 个研究点目标入组 575 人开始时间: 2021年3月19日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
575

研究概览

简要总结

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37095137/ (added 14/05/2024)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Individuals receiving any of the SARS-CoV-2 vaccines approved in Switzerland at the Corona Center of the UZH
  • 2. Aged =18 years,
  • 3. Able to follow the study procedures
  • 4. Providing informed consent

排除标准

  • 1. Having insufficient knowledge of the German language
  • 2. Individuals whose primary residence is outside of the Canton of Zurich
  • 3. Previously received SARS-CoV-2 vaccine

研究者

发起方
niversity of Zurich

相似试验